Latest 10-K annual reports
NASDAQ
FORA
Forian INC10-K: Forian Inc. Reports Restated 2024 Annual Results, Cites Material Weaknesses in Internal Controls
Forian Inc.'s 10-K filing reveals restated financial statements for 2023 due to revenue recognition errors and identifies material weaknesses in internal controls over financial reporting.
Patria Latin American Opportunity Acquisition Corp., a SPAC focused on Latin American opportunities, reported a significant net loss in 2024, faces delisting from Nasdaq due to non-compliance and failure to complete a business combination within the required timeframe, and has identified material weaknesses in its internal controls, raising substantial doubt about its ability to continue as a going concern.
10-K: Signing Day Sports, Inc. Details Securities, Financials, and Risk Factors in Annual 10-K Filing
Signing Day Sports, Inc. files its annual report on Form 10-K, outlining its business, financial condition, risk factors, and description of securities.
Unity Biotechnology files an amendment to its 2024 Annual Report on Form 10-K to include updated information on directors, executive officers, compensation, and related matters.
NASDAQ
PROCEPT BioRobotics Corporation files an amendment to its annual report to include its Insider Trading Compliance Policy and Procedures, which was inadvertently omitted from the original filing.
TNF Pharmaceuticals provides a summary of its capital stock, including common and preferred shares, in its latest 10-K filing.
AMEX
IT Tech Packaging's annual report reveals a revenue decrease primarily due to lower sales and prices in its corrugating medium paper segment, coupled with production suspensions.
NASDAQ
10-K: DBV Technologies Reports Full Year 2024 Results, Outlines Path to Potential Viaskin Peanut Approval
DBV Technologies reports its full year 2024 results and provides updates on its Viaskin Peanut program, including a potential accelerated approval pathway.
OID
Lingerie Fighting Championships, Inc. files its annual report on Form 10-K, outlining financial performance and agreements related to warrants and convertible notes.
CSLM Acquisition Corp.'s 10-K filing reveals ongoing efforts to complete a business combination with Fusemachines amid challenges including a Nasdaq delisting notice and going concern uncertainties.
NYSE
AES
Aes CORPAES Corporation amended its 2024 annual report to include previously omitted exhibits and secured a $300 million credit agreement.
AMEX
Planet Green Holdings Corp.'s 2024 annual report reveals a decrease in net revenues and a net loss, alongside strategic business adjustments and ongoing legal proceedings.
AIBotics, Inc.'s 2024 10-K filing reveals a widened net loss and a strategic shift towards artificial intelligence and robotics, particularly in the wellness and parenting sectors.
NASDAQ
CETX
Cemtrex INCCemtrex Inc. files an amendment to its Form 10-K for the fiscal year ended September 30, 2024, to include its Clawback Policy as required by SEC Rule 10D-1.
NYSE
KMX
Carmax INCCarMax's fiscal year 2025 saw a slight revenue decrease but improved gross profit, strategic investments in omni-channel platform, and focus on operational efficiencies.
NASDAQ
Where Food Comes From, Inc. amends its annual report to update the linked file for Exhibit 97, detailing the company's policy on recovery of incentive-based compensation from executive officers in the event of an accounting restatement.
OQB
I-ON Digital Corp. reports its annual results for the fiscal year ended December 31, 2024, highlighting its strategic shift towards asset digitization and securitization solutions, including the acquisition of Orebits Corp.
NASDAQ
Black Hawk Acquisition Corporation files an amendment to its annual report on Form 10-K to include the Executive Compensation Recovery Policy (Clawback Policy) that was inadvertently omitted in the original filing.
OTC.Pink
Quest Water Global's 2024 annual report reveals no revenue, a net loss, and continued reliance on related-party funding, raising substantial doubt about the company's ability to continue as a going concern.
NYSE
TLYS
Tilly's, INCTillys, Inc. reports a decrease in net sales and a widened operating loss for fiscal year 2024, citing persistent inflation and decreased consumer confidence.
OTC.Pink
CannaPharmaRx's 10-K filing reveals a net loss of $9.9 million for 2024, despite generating $820,137 in revenue for the first time, as the company navigates strategic shifts and operational challenges.
NASDAQ
10-K: SHF Holdings Reports Fiscal Year 2024 Results, Navigates Nasdaq Compliance and Restructures Debt
SHF Holdings, a financial services provider for the cannabis industry, announces its fiscal year 2024 results, addresses Nasdaq listing compliance, and restructures its debt with Partner Colorado Credit Union (PCCU).
MINM
Minim, INCFiEE Inc. reports a significant decrease in net sales for fiscal year 2024 and outlines its strategic shift towards integrating AI and data analytics into digital content creation and brand management.
NYSE
Equus Total Return, Inc.'s 2024 10-K filing reveals a strategic focus on transforming into an operating company amidst financial headwinds and a shift in investment approach.
TLLTF
Tilt Holdings INCTILT Holdings Inc. files its 10-K for the year ended December 31, 2024, detailing financial results, strategic shifts, and ongoing efforts to address debt and explore strategic alternatives.
NASDAQ
LOVE
Lovesac CO10-K: Lovesac's Fiscal 2025: Sales Dip Slightly, But Profitability Remains Positive Amid Strategic Shifts
Lovesac reports a slight decrease in net sales for fiscal 2025, but maintains profitability through strategic cost management and gross margin improvements.
NYSE
Karman Holdings Inc. announces a 23.0% year-over-year revenue increase to $345.3 million and a net income of $12.7 million for the fiscal year ended December 31, 2024, driven by growth across its core end markets.
Yong Bai Chao New Retail Corporation files its 10-K report for the year ended December 31, 2024, highlighting ongoing leadership transitions, minimal operations, and the pursuit of a business combination.
NASDAQ
Bitcoin Depot Inc. files an amendment to its 2024 annual report to include the company's clawback policy and insider trading policy as exhibits.
10-K/A: Entero Therapeutics Faces Going Concern Doubts Amid Strategic Shifts and Financial Challenges
Entero Therapeutics reports ongoing losses and explores strategic alternatives, including a potential rescission agreement with ImmunogenX, raising concerns about its ability to continue as a going concern.